The clinical use of adjuvants in pneumococcal vaccination: current status and future perspectives. 2011

Ole Schmeltz Søgaard
Aarhus University Hospital-Skejby, Department of Infectious Diseases, Aarhus N, Denmark. olesoega@rm.dk

UI MeSH Term Description Entries
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D022242 Pneumococcal Vaccines Vaccines or candidate vaccines used to prevent infections with STREPTOCOCCUS PNEUMONIAE. Pneumococcal Polysaccharide Vaccine,Pneumococcal Vaccine,Pneumovax,Pnu-Imune Vaccine,Pnu Imune Vaccine,PnuImune Vaccine,Polysaccharide Vaccine, Pneumococcal,Vaccine, Pneumococcal,Vaccine, Pneumococcal Polysaccharide,Vaccines, Pneumococcal

Related Publications

Ole Schmeltz Søgaard
June 1993, Immunology today,
Ole Schmeltz Søgaard
May 1993, Trends in pharmacological sciences,
Ole Schmeltz Søgaard
January 2022, Frontiers in immunology,
Ole Schmeltz Søgaard
January 2005, Bratislavske lekarske listy,
Ole Schmeltz Søgaard
July 2001, The European respiratory journal,
Ole Schmeltz Søgaard
January 2011, The Kaohsiung journal of medical sciences,
Ole Schmeltz Søgaard
December 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Ole Schmeltz Søgaard
May 2020, Seminars in nuclear medicine,
Copied contents to your clipboard!